Huntingtin-interacting protein 14 is a type 1 diabetes candidate protein regulating insulin secretion and β-cell apoptosis

Type 1 diabetes (T1D) is a complex disease characterized by the loss of insulin-secreting β-cells. Although the disease has a strong genetic component, and several loci are known to increase T1D susceptibility risk, only few causal genes have currently been identified. To identify disease-causing genes in T1D, we performed an in silico “phenome–interactome analysis” on a genome-wide linkage scan dataset. This method prioritizes candidates according to their physical interactions at the protein level with other proteins involved in diabetes. A total of 11 genes were predicted to be likely disease genes in T1D, including the INS gene. An unexpected top-scoring candidate gene was huntingtin-interacting protein (HIP)-14/ZDHHC17. Immunohistochemical analysis of pancreatic sections demonstrated that HIP14 is almost exclusively expressed in insulin-positive cells in islets of Langerhans. RNAi knockdown experiments established that HIP14 is an antiapoptotic protein required for β-cell survival and glucose-stimulated insulin secretion. Proinflammatory cytokines (IL-1β and IFN-γ) that mediate β-cell dysfunction in T1D down-regulated HIP14 expression in insulin-secreting INS-1 cells and in isolated rat and human islets. Overexpression of HIP14 was associated with a decrease in IL-1β–induced NF-κB activity and protection against IL-1β–mediated apoptosis. Our study demonstrates that the current network biology approach is a valid method to identify genes of importance for T1D and may therefore embody the basis for more rational and targeted therapeutic approaches.

[1]  A. Nordström,et al.  What's next for WHO? , 2006, The Lancet.

[2]  M. Uhler,et al.  Transient transfection studies of secretion in bovine chromaffin cells and PC12 cells. Generation of kainate-sensitive chromaffin cells. , 1993, The Journal of biological chemistry.

[3]  Denis Soulet,et al.  Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretion. , 2009, Human molecular genetics.

[4]  Shouguo Gao,et al.  Predicting Type 1 Diabetes Candidate Genes using Human Protein-Protein Interaction Networks , 2009, Journal of computer science and systems biology.

[5]  A. K. Cardozo,et al.  The Cytokine Interleukin-1β Reduces the Docking and Fusion of Insulin Granules in Pancreatic β-Cells, Preferentially Decreasing the First Phase of Exocytosis* , 2004, Journal of Biological Chemistry.

[6]  F. Bosch,et al.  Overexpression of Kinase-Negative Protein Kinase Cδ in Pancreatic β-Cells Protects Mice From Diet-Induced Glucose Intolerance and β-Cell Dysfunction , 2009, Diabetes.

[7]  J. Todd,et al.  Genome-Wide Scan for Linkage to Type 1 Diabetes in 2,496 Multiplex Families From the Type 1 Diabetes Genetics Consortium , 2009, Diabetes.

[8]  S. Rich.  Genetic Epidemiological Perspective , 2006 .

[9]  Kathrin Maedler,et al.  Inflammatory mediators and islet β-cell failure: a link between type 1 and type 2 diabetes , 2003, Journal of Molecular Medicine.

[10]  P. Robinson,et al.  Walking the interactome for prioritization of candidate disease genes. , 2008, American journal of human genetics.

[11]  E. Isacoff,et al.  Drosophila Huntingtin-Interacting Protein 14 Is a Presynaptic Protein Required for Photoreceptor Synaptic Transmission and Expression of the Palmitoylated Proteins Synaptosome-Associated Protein 25 and Cysteine String Protein , 2007, The Journal of Neuroscience.

[12]  Alan R. Powell,et al.  Integration of text- and data-mining using ontologies successfully selects disease gene candidates , 2005, Nucleic acids research.

[13]  N. Welsh,et al.  High Glucose Suppresses Human Islet Insulin Biosynthesis by Inducing miR-133a Leading to Decreased Polypyrimidine Tract Binding Protein-Expression , 2010, PloS one.

[14]  J. Caviston,et al.  Huntingtin as an essential integrator of intracellular vesicular trafficking. , 2009, Trends in cell biology.

[15]  Xia Yang,et al.  Integrating pathway analysis and genetics of gene expression for genome-wide association studies. , 2010, American journal of human genetics.

[16]  D. Schorderet,et al.  Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death. , 2001, Diabetes.

[17]  Helen Schuilenburg,et al.  Genome-wide association study and meta-analysis finds over 40 loci affect risk of type 1 diabetes , 2009, Nature Genetics.

[18]  Michael Boehnke,et al.  LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..

[19]  P. De Camilli,et al.  A role for synaptic vesicles in non‐neuronal cells: clues from pancreatic β cells and from chromaffin cells , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  C. Wijmenga,et al.  Reconstruction of a functional human gene network, with an application for prioritizing positional candidate genes. , 2006, American journal of human genetics.

[21]  Yongjin Li,et al.  Discovering disease-genes by topological features in human protein-protein interaction network , 2006, Bioinform..

[22]  Pall I. Olason,et al.  A human phenome-interactome network of protein complexes implicated in genetic disorders , 2007, Nature Biotechnology.

[23]  O. Madsen,et al.  Beta-cell maturation leads to in vitro sensitivity to cytotoxins. , 1999, Diabetes.

[24]  Amitabh Sharma,et al.  Gene prioritization in Type 2 Diabetes using domain interactions and network analysis , 2010, BMC Genomics.

[25]  S. Akira,et al.  Toll-like Receptor 3 and STAT-1 Contribute to Double-stranded RNA+ Interferon-γ-induced Apoptosis in Primary Pancreatic β-Cells* , 2005, Journal of Biological Chemistry.

[26]  S. Morris,et al.  Expression of the citrulline-nitric oxide cycle in rodent and human pancreatic beta-cells: induction of argininosuccinate synthetase by cytokines. , 1995, Endocrinology.

[27]  J. Castle,et al.  An integrative genomics approach to infer causal associations between gene expression and disease , 2005, Nature Genetics.

[28]  D. C. Thurmond,et al.  Syntaxin 4 facilitates biphasic glucose-stimulated insulin secretion from pancreatic beta-cells. , 2006, Molecular endocrinology.

[29]  S. Hersch,et al.  HIP14, a novel ankyrin domain-containing protein, links huntingtin to intracellular trafficking and endocytosis. , 2002, Human molecular genetics.

[30]  D. Schorderet,et al.  Cell-Permeable Peptide Inhibitors of JNK: Novel Blockers of β-Cell Death , 2001 .

[31]  Torben F. Ørntoft,et al.  Cytokines Interleukin-1β and Tumor Necrosis Factor-α Regulate Different Transcriptional and Alternative Splicing Networks in Primary β-Cells , 2009, Diabetes.

[32]  M. Hurlbert,et al.  Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes. , 1999, Diabetes.

[33]  D. Eizirik,et al.  Inhibition of cytokine-induced NF-kappaB activation by adenovirus-mediated expression of a NF-kappaB super-repressor prevents beta-cell apoptosis. , 2001, Diabetes.

[34]  C. Polychronakos,et al.  Mechanisms of genetic susceptibility to type I diabetes: beyond HLA. , 2004, Molecular genetics and metabolism.

[35]  C. Wijmenga,et al.  Using genome‐wide pathway analysis to unravel the etiology of complex diseases , 2009, Genetic epidemiology.

[36]  Lu Gan,et al.  Palmitoylation of huntingtin by HIP14is essential for its trafficking and function , 2006, Nature Neuroscience.

[37]  T. Ueda,et al.  Glutamate transport and storage in synaptic vesicles. , 1998, Japanese journal of pharmacology.

[38]  S. Rich.  Mapping Genes in Diabetes: Genetic Epidemiological Perspective , 1990, Diabetes.

[39]  P. Serup,et al.  The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic beta-cells. , 2000, Diabetes.

[40]  Charles D Smith,et al.  Huntingtin interacting protein 14 is an oncogenic human protein: palmitoyl acyltransferase , 2004, Oncogene.

[41]  P. Verstreken,et al.  Huntingtin-interacting protein 14, a palmitoyl transferase required for exocytosis and targeting of CSP to synaptic vesicles , 2007, The Journal of cell biology.

[42]  M. Donath,et al.  Cytokines and beta-cell biology: from concept to clinical translation. , 2008, Endocrine reviews.

[43]  John A. Todd,et al.  Genetics of Type 1 Diabetes: What's Next? , 2010, Diabetes.

[44]  Erik Renström,et al.  The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient beta-cell mass and exocytosis. , 2005, Human molecular genetics.

[45]  C. Wollheim,et al.  Mitochondrial glutamate acts as a messenger in glucose-induced insulin exocytosis , 1999, Nature.

[46]  Nils Welsh,et al.  Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. , 2005, Diabetes.

[47]  M. Trucco,et al.  Protection of Human Islets from the Effects of Interleukin-1β by Adenoviral Gene Transfer of an IκB Repressor* , 2000, The Journal of Biological Chemistry.

[48]  Paul A Lyons,et al.  Combining mouse congenic strains and microarray gene expression analyses to study a complex trait: the NOD model of type 1 diabetes. , 2002, Genome research.

[49]  P. Meda,et al.  Involvement of MicroRNAs in the Cytotoxic Effects Exerted by Proinflammatory Cytokines on Pancreatic β-Cells , 2010, Diabetes.

[50]  M. Bugliani,et al.  PTPN 2 , a candidate gene for type 1 diabetes , modulates interferon-gamma-induced pancreatic beta-cell apoptosis , 2009 .

[51]  P. Robbins,et al.  Protection of human islets from the effects of interleukin-1beta by adenoviral gene transfer of an Ikappa B repressor. , 2000, The Journal of biological chemistry.

[52]  Grant Morahan,et al.  Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families. , 2005, Diabetes.

[53]  M. Donath,et al.  Cytokines and β-Cell Biology: from Concept to Clinical Translation , 2008 .

[54]  J. Zhu,et al.  An integrative genomics approach to the reconstruction of gene networks in segregating populations , 2004, Cytogenetic and Genome Research.

[55]  T. Mandrup-Poulsen,et al.  A choice of death – the signal-transduction of immune-mediated beta-cell apoptosis , 2001, Diabetologia.

[56]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[57]  S. Theander,et al.  Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells. , 2004, Endocrinology.

[58]  D. Sax,et al.  Increased frequency of diabetes mellitus in patients with Huntington's chorea. , 1972, Lancet.

[59]  V. Kostic,et al.  Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion. , 2008, Archives of neurology.

[60]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[61]  Claire-Anne Gutekunst,et al.  Huntingtin-Interacting Protein HIP14 Is a Palmitoyl Transferase Involved in Palmitoylation and Trafficking of Multiple Neuronal Proteins , 2004, Neuron.

[62]  J. Rothman,et al.  Functional mapping of disease susceptibility loci using cell biology. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[63]  M. Redondo,et al.  Genetics of type 1A diabetes. , 2001, Recent progress in hormone research.